Jun 10, 2020 / 01:00PM GMT
John Charles Kreger - William Blair & Company L.L.C., Research Division - Partner & Healthcare Services Analyst
Good morning, everyone. This is John Kreger. Thank you for joining us on day 2 of the William Blair 40th Annual Growth Stock Conference. Our next session is Catalent. With us from the company, we have Wetteny Joseph, the CFO; as well as Paul Surdez, the Head of IR.
We're going to take the next 30 minutes to go through a fireside chat Q&A session with Wetteny. You guys, as listeners, will have the opportunities to submit questions via the chat feature to me, and I will do my best to include those time permitting. I do need to tell you that, as the research analyst here at William Blair that covers Catalent, you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
And I think we're going to start with Wetteny just giving a little bit of an intro on what's happening at Catalent, and then we'll jump into questions. Wetteny, you want to start?
Wetteny N. Joseph - Catalent, Inc. - Senior
Catalent Inc at William Blair Growth Stock Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot